Background and the Purpose of the Study: Patients undergoing high-dose chemotherapy for hematological malignancies are susceptible to development of oral mucositis, and no effective modality has been reported for its prophylaxis and treatment. The aim of this study was to evaluate the effectiveness of zinc mouthwash on chemotherapy-induced oral mucositis lesions. Methods: In this double-blind randomized trial, patients under chemotherapy for acute leukemia were divided into two test and control groups of 15 patients each. The groups were homogeneous with respect to medical history, tumor characteristics, and therapeutic details. The test group received 10ml 0.2% zinc sulfate mouthwash, and the control group received 10ml 0.2% chlorhexidine gluconate mouthwash, twice a day for a period of two weeks. Spijkervet scale was used to grade the severity of mucositis at every other week during eight weeks. The severity scores were analyzed with repeated measure ANOVA using SPSS 13.0 computer software. Results: Mean severity scores were generally lower in the test group compared to the controls at all four time intervals evaluated; but only, the differences in weeks of 2 and 3 were statistically significant (P=0.025). Conclusion: Zinc mouthwash used in conjunction with chemotherapy may reduce the severity of oral mucositis lesions in patients with leukaemia.
INTRODUCTION
Oral mucositis is a condition characterized by damages to the epithelium of the oral cavity, pharynx, and gastrointestinal tract from chemical irritations, radiation therapy, or chemotherapy for a hematological malignancy (1) . Many protocols have been proposed to prevent or reduce the severity of oral mucositis, but no treatment modality is yet known to be a definite prophylactic agent (2) . Although chlorhexidine gluconate mouthwash is traditionally used in patients with oral mucositis, there is little evidence to recommend it as a gold standard. While some reports indicate positive effects of chlorhexidine mouth rinse on oral mucositis, recent studies have found either no effect or even negative effects (3). The bitter taste, dental pigmentation, dysgeusia, and unpleasant sensation experienced together with ineffectiveness provide sufficient reasons for recommending an alternative to the chlorhexidine mouthwash (4) . Among medications with wound healing effects, zinc sulphate seems to be one of the promising agents in mucositis prevention (5) . Zinc is an essential cofactor in various cellular processes such as DNA synthesis, RNA polymerase and reverse transcriptase, and has effects on wound healing, growth and immunity. The growth and reproductive effects of zinc are related to its influences on DNA synthesis, protein synthesis, and cell division (6) . Considering the effects of zinc on re-epithelialization and wound healing, the aim of this study was to evaluate the effectiveness of a zinc-containing mouthwash on chemotherapy-induced oral mucositis, in comparison with chlorhexidine gluconate mouthwash as control.
MATERIAL AND METHODS
In this double-blind randomized study, patients were selected from those with acute leukemia under chemotherapy in the oncology ward of Shahid Gazi Hospital in Tabriz, Iran. Patient data including age, gender, the history of chemotherapy, the dose of the drug, and any known allergy to mouthwashes were recorded by means of a questionnaire. Patients under chemotherapy on the basis an established treatment plan for acute myeloid leukemia (Cytarabine in the induction phase, and Novantrone in the consolidation phase) were included in this study. Exclusion FULWHULD LQFOXGHG DJH \HDUV ROG DQ\ V\VWHPLF disease with other diagnosis of malignancies or chemotherapy-induced oral mucositis, any oral ulcers and mucosistis developed before starting chemotherapy, known allergy to zinc-containing or chlorhexidine mouthwashes. All probable risks and EHQH¿WV RI WKH VWXG\ ZHUH H[SODLQHG WR WKH SDWLHQWV guardians. Upon inclusion in the study, subjects gave written informed consents. The study protocol was approved by the Research Ethics Committee at Tabriz University of Medical Sciences. A total of 30 patients were selected, and matched with respect to medical history, tumor characteristics, and therapeutic details. Subjects were allocated to experimental and control groups of 15 patients each. The required dilution of (0.2%) zinc sulphate and chlorhexidine gluconate mouthwashes were prepared in the department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. Patients were instructed to rinse with 10 ml of 0.2% zinc sulphate mouthwash two times par day for 14 days in the experimental group, and with10 ml of 0.2% chlorhexidine mouthwash in the same manner in the control group. The mouthwashes were FRGHG ZLWK µ$ ¶ DQG µ% ¶ OHWWHUV RQ WKH ERWWOHV DQG WKH investigator as well as the subjects were blinded to the type of the mouthwash which was administered to the groups by a simple random method. All patients were examined every other week for GXULQJ HLJKW ZHHNV 7KH HI¿FDF\ RI WKH WUHDWPHQW DW each session was determined by recording the length (E) of the lesion, measured by a digital caliper, and its severity (K), based on local signs, according to the Spijkervet scale (7). Eight distinguishable irradiated areas of the mouth including buccal mucosa (left & right), soft and hard palate, dorsum and border of the tongue (left & right) and the PRXWK ÀRRU ZHUH HYDOXDWHG 7DEOH 7KH VFRUH RI HDFK DUHD ZDV GH¿QHG DV WKH SURGXFW RI WKH OHQJWK DQG VHYHULW\ VFRUH 7KH PXFRVLWLV VFRUH Į LQ HDFK LQGLYLGXDO ZDV GH¿QHG DV WKH PHDQ RI WKH VFRUHV assigned to the evaluated areas, and ranged from 0 to 16. Independent t-test was used to reveal any probability of differences between groups in the baseline. The mucositis score changes for the two groups during the four weeks were compared using the repeated PHDVXUH $129$ 6WDWLVWLFDO VLJQL¿FDQFH OHYHO ZDV VHW DW S 7KH GDWD ZHUH DQDO\]HG XVLQJ 6366 13.0 computer software. Oral administration of the drug could also be considered, although it would entail the assessment of the serum level of the medication. In the present study, a lower severity of oral mucositis was found in the patients receiving zinc-containing PRXWKZDVK ZKLFK LV LQ DFFRUGDQFH ZLWK WKH ¿QGLQJV RI SUHYLRXV VWXGLHV &RQÀXHQW PXFRVLWLV ZDV also reported to improve fast in the zinc sulfate group in comparison to the placebo group (9). Lin et al. (10) have reported that zinc supplementation in conjunction with radiotherapy postponed the development of severe mucositis in patients with oral cancers (10) . Chlorhexidine, as an oral rinse, has been also evaluated in several randomized clinical trials for preventing oral mucositis (4) . A meta-analysis, however, has shown no effect for chlorhexidine in the prevention of mucositis in patients under chemotherapy and radiotherapy (2) . The results of the present study also showed relatively higher scores of oral mucositis in patients receiving 
